|
|
| A Full-Service Solution Partner Disrupting the Outsourcing Paradigm | inSeption Group is a global full-service outsourcing organization that has resurrected a common-sense approach to rebuild business trust and confidence in a client’s selected vendor. Primarily focused on oncology, hematology, neurodegenerative disorders, and rare/orphan disease indications, with a specialization in cell and gene therapy, inSeption has been a solution for its’ clients who have experienced the progressive degradation of today’s outsourcing options. Contact them. |
|
|
|
|
Generative AI is making an impact across functional areas at life sciences companies. This article provides current examples and use cases from drug discovery and clinical trials to manufacturing, commercialization, and patient monitoring. |
|
|
|
The biopharmaceutical industry is building manufacturing capacity at breakneck speed. According to PhRMA, there are 1,580-and-counting biopharma manufacturing facilities in the U.S. alone. Problem is, we're way short on filling those facilities with skilled labor. NIIMBL wants to change that. Here's how, and a great opportunity for big pharma, biotech sponsors, CDMOs, academics, and more to help. |
|
|
|
|
| The AI Impact with Generate: Biomedicines' Mike Nally | Few drug discovery and development concepts are as hyped as machine learning and AI. One company on the bullish end of the spectrum is Flagship Pioneering's Generate: Biomedicines, which bills itself at the "intersection of machine learning, biological engineering, and medicine." Learn about the "generative biology" work it's doing and the AI/ML impact it anticipates as Business of Biotech sits down with Mike Nally, CEO at Generate and CEO-Partner at Flagship Pioneering. |
|
|
|
|
|
|
|
CONTRIBUTE TO LIFE SCIENCE LEADER |
|
|
|
Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director. |
|
|
Connect With Life Science Leader: |
|
|
|